“Peg-Interferon Plus Ribavirin in Chronic Hepatitis C: Cost-Efficacy and Pharmacoutilization in Clinical Practice”. 2008. Farmeconomia. Health Economics and Therapeutic Pathways 9 (4): 173-81. https://doi.org/10.7175/fe.v9i4.235.